# Diasome Pharmaceuticals: Biotechnology, Cleveland, United States

> Diasome Pharmaceuticals: Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies.

Source: https://millionrounds.com/startup/diasome-pharmaceuticals (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# Diasome Pharmaceuticals

Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies.

Funding reported Last round: Undisclosed round

Biotechnology Cleveland, United States

Company summary

- **Founded:** 2004 22 years old
- **Team:** 1 1 to 10 people
- **Funding reported:** $92M in dollars
- **Last round:** Undisclosed round Jun 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Diasome Pharmaceuticals has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Diasome Pharmaceuticals raised

Funding, as reported

Reported in all **$92M** in dollars

Rounds **7**

Last round **Undisclosed round**

Last round date **Jun 2023**

Investors listed **6**

SEC Form D **$63M sold, 8 filings, last Aug 2024**

## Founders and team

From Diasome Pharmaceuticals's own website: 5 on the team.

- **J. Lincoln Chapin** Vice President of Clinical Operations
- **Linda Rubinstein** Chief Financial Officer
- **Eric Edidin** Board Chairman
- **Frank McCaney** Director
- **Thomas McDonald** Director

## On 3 portfolio pages

Investors who name them

- [T1D Fund](https://millionrounds.com/fund/t1d-fund)
- [Endo Investors](https://millionrounds.com/fund/endo-investors)
- [Green Isle Capital](https://millionrounds.com/fund/green-isle-capital)

Each firm lists Diasome Pharmaceuticals on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biotechnology in United States

Startups like it

- [**Sojournix** Waltham · founded 2016 *Raised*](https://millionrounds.com/company/sojournix)
- [**Receptor Life Sciences** Seattle · founded 2017 *Raised*](https://millionrounds.com/company/receptor-life-sciences)
- [**Attune Pharmaceuticals** New York · founded 2018 *Raised*](https://millionrounds.com/company/attune-pharmaceuticals)
- [**AbbVie** North Chicago · founded 2012](https://millionrounds.com/startup/abbvie-2)
- [**Grail** Menlo Park · founded 2015](https://millionrounds.com/startup/grail-3)
- [**EQRx** Cambridge · founded 2019](https://millionrounds.com/startup/eqrx)
- [**Cerevel Therapeutics** Boston · founded 2018](https://millionrounds.com/startup/cerevel-therapeutics)
- [**Royalty Pharma** New York · founded 1996](https://millionrounds.com/startup/royalty-pharma)

## Is this your company?

Add your raise, your deck and your story, and put Diasome Pharmaceuticals in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)